The Ozempic boom could be bad news for restaurants as more than half of GLP-1 users report cutting back on dining out, report finds

A group of young women sit around a table at a restaurant. (Credit: Getty Images)

• GLP-1 users taking drugs like Ozempic and Wegovy are spending less on eating at restaurants and on take-out dinners, according to a new report from Bloomberg Intelligence. Changing eating habits add to a growing number of headwinds the hospitality industry faces as a result of slow pandemic recovery and tariff-induced economic uncertainty.

As restaurants grapple with how diners are responding to economic uncertainty, they may also have to contend with consumer pullbacks as a result of the rise of drugs like Ozempic and Wegovy.